Portside Wealth Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Portside Wealth Group's HALO Position: Q3 2026 in Review
Portside Wealth Group increased its Halozyme (HALO) stake by 77% in Q3 2026, buying an estimated $630K and bringing the position to 15,027 shares worth $1.66M. The position accounts for 0.18% of the portfolio, ranked #116.
Portside Wealth Group first reported a position in HALO in Q3 2023 and has held it in 11 quarters since. 308 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Portside Wealth Group held 15,027 shares of Halozyme worth $1.66M as of Q3 2026.
- Portside Wealth Group bought 6,522 Halozyme shares in Q3 2026, an estimated $630K.
- Halozyme made up 0.18% of Portside Wealth Group's portfolio in Q3 2026, its #116 holding.
- Portside Wealth Group first reported a position in Halozyme in Q3 2023 and has held it in 11 quarters since.
- 308 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.